You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The team will use the five-year funding to develop a liquid biopsy-based assay to select and prioritize liver cancer patients who need a liver transplant.
The program will aim to develop and evaluate genomics and informatics tools to improve the diagnosis, treatment, and prevention of disease.
The National Human Genome Research Institute and the National Cancer Institute also intend to fund the dissemination of genomic resources to the research community.
Gladstone Institutes researchers will use proteomic, genomic, and gene-altering approaches to investigate apoe4 toxicity as part of a five-year project.
The panels will select candidate genes that will have a high impact on clinical practice in areas of high priority for participating institutes and centers.
The seven-year grant renews funding for the Antibacterial Resistance Leadership Group, led by Duke University and UCSF, with $15 million in 2020.
The five-year funding commitment represents a 5 percent increase over the previous grant period for the rapidly growing archive of 3D protein structures.
The Hayward, California-based firm aims to tailor its NX One sample prep platform to isolate and detect cancer stem cells in urothelial cancer of the bladder.
The firm will use the funding to build a high-throughput flow cytometry system that sorts cells based on high-content 3D features.
The firm will validate a model system for test development, integrate key test components, and compare Spotlight to other NIPT assays.
New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.
A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.
Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.
In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.